SCN9A Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant SCN9A.
|Calculated MW||226372 Da|
|Other Names||Sodium channel protein type 9 subunit alpha, Neuroendocrine sodium channel, hNE-Na, Peripheral sodium channel 1, PN1, Sodium channel protein type IX subunit alpha, Voltage-gated sodium channel subunit alpha Nav17, SCN9A, NENA|
|Target/Specificity||SCN9A (NP_002968, 269 a.a. ~ 339 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||SCN9A Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder.
Sodium channel Na v 1.7 immunoreactivity in painful human dental pulp and burning mouth syndrome. Beneng K, et al. BMC Neurosci, 2010 Jun 8. PMID 20529324. Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia. Choi JS, et al. Brain, 2010 Jun. PMID 20478850. Mutations at opposite ends of the DIII/S4-S5 linker of sodium channel Na V 1.7 produce distinct pain disorders. Cheng X, et al. Mol Pain, 2010 Apr 29. PMID 20429905. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, et al. Mol Med, 2010 Jul-Aug. PMID 20379614. Pain perception is altered by a nucleotide polymorphism in SCN9A. Reimann F, et al. Proc Natl Acad Sci U S A, 2010 Mar 16. PMID 20212137.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.